IVD Medical (HKG:1931) established a US subsidiary as part of a broader effort to launch its own cryptocurrency, according to a Hong Kong bourse filing Sunday.
Shares of the medical equipment seller jumped nearly 31% in morning trade Monday.
The move follows the signing of the Guiding and Establishing National Innovation for U.S. Stablecoins Act, or Genius Act, by US President Donald Trump.
IVD Medical's US subsidiary is laying the groundwork for pursuing a stablecoin license in the country, IVD Medical said.
The company previously said it was pursuing a web3 exchange focused on tokenizing its intellectual property and planned to issue its own stablecoin as part of that process.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。